Concepedia

Kush Dhody

KD

Statistics

Publications

8

Citations

427

H-Index

8

Active since

2015

Affiliations

Oregon Health & Science University(Current)

Weill Cornell Medicine

Cornell University

Oregon National Primate Research Center

University of Hawaii System

Kush Dhody is an author at Oregon Health & Science University specializing in immunology, antiviral therapy, and infectious diseases.

ORCID

Publications per year

2015–2022

8

Publications

8

CCR5 inhibition in critical COVID-19 patients decreases inflammatory cytokines, increases CD8 T-cells, and decreases SARS-CoV2 RNA in plasma by day 14

Bruce K. Patterson, Harish Seethamraju, Kush Dhody et al. · International Journal of Infectious Diseases · 2020 · 147 citations · Full text

, , +17

Disruption of the CCL5/RANTES-CCR5 Pathway Restores Immune Homeostasis and Reduces Plasma Viral Load in Critical COVID-19

Bruce K. Patterson, Harish Seethamraju, Kush Dhody et al. · medRxiv · 2020 · 104 citations · Full text

, , +17

PRO 140, a monoclonal antibody targeting CCR5, as a long-acting, single-agent maintenance therapy for HIV-1 infection

Kush Dhody, Nader Pourhassan, Kazem Kazempour et al. · HIV Clinical Trials · 2018 · 50 citations

, , +16

Clinical Characteristics and Outcomes of Coronavirus Disease 2019 Patients Who Received Compassionate-Use Leronlimab

Bryant D. Yang, Jennifer A. Fulcher, Jenny Ahn et al. · Clinical Infectious Diseases · 2020 · 36 citations · Full text

, , +12

Safety and efficacy of a novel silver-impregnated urinary catheter system for preventing catheter-associated bacteriuria: A pilot randomized clinical trial

Anne‐Marie Leuck, James R. Johnson, Matthew A. Hunt et al. · American Journal of Infection Control · 2015 · 33 citations · Full text

, , +16

1–5 of 8